Financials
In this section you will find Fiskars Group’s key financial information, such as long-term financial targets, key figures, financial position and guidance.
Five years in figures
2023 | 2022 | 2021 | 2020 | 2019 | ||
Net sales | EUR million | 1,129.8 | 1,248.4 | 1,254.3 | 1,116.2 | 1,090.4 |
of which outside Finland | EUR million | 1,024.0 | 1,136.0 | 1,142.0 | 1,021.9 | 977.5 |
in percent of net sales | % | 90.6 | 91.0 | 91.0 | 91.5 | 89.6 |
export from Finland | EUR million | 21.2 | 20.4 | 24.2 | 20.1 | 20.2 |
Change of net sales, % | % | -9.5 | -0.5 | 12.4 | 2.4 | -2.5 |
Gross profit | EUR million | 511.4 | 555.9 | 539.8 | 452.0 | 447.3 |
% of net sales | % | 45.3 | 44.5 | 43.0 | 40.5 | 41.0 |
EBIT | EUR million | 98.9 | 134.7 | 142.8 | 98.0 | 60.1 |
% of net sales | % | 8.7 | 10.8 | 11.4 | 8.8 | 5.5 |
Comparable EBIT | EUR million | 110.3 | 151.0 | 154.2 | 109.0 | 77.8 |
Comparable EBITDA | EUR million | 175.8 | 210.3 | 215.7 | 185.1 | 137.3 |
Change in fair value of biological assets | EUR million | 4.8 | 1.1 | 1.3 | 0.7 | -0.2 |
Financial items net | EUR million | -24.0 | -11.7 | 0.0 | -8.9 | 3.4 |
% of net sales | % | -2.1 | -0.9 | 0.0 | -0.8 | 0.3 |
Profit before taxes | EUR million | 79.7 | 124.1 | 144.1 | 89.8 | 63.2 |
% of net sales | % | 7.1 | 9.9 | 11.5 | 8.0 | 5.8 |
Income tax | EUR million | -9.7 | -25.0 | -56.5 | -21.3 | -10.8 |
Profit for the period attributable to the equity holders in the parent company | EUR million | 69.9 | 98.2 | 86.6 | 67.6 | 51.7 |
% of net sales | % | 6.2 | 7.9 | 6.9 | 6.1 | 4.7 |
Non-controlling interests | EUR million | 0.2 | 0.9 | 0.9 | 0.8 | 0.7 |
Employee benefits | EUR million | 289.2 | 289.0 | 293.7 | 262.9 | 311.9 |
Depreciation, amortization and impairment | EUR million | 66.0 | 59.4 | 61.6 | 76.1 | 59.6 |
% of net sales | % | 5.8 | 4.8 | 4.9 | 6.8 | 5.5 |
Cash flow from operating activities | EUR million | 220.8 | -61.4 | 122.9 | 199.2 | 96.5 |
Capital expenditure | EUR million | 50.8 | 48.1 | 34.4 | 30.0 | 40.0 |
% of net sales | % | 4.5 | 3.9 | 2.7 | 2.7 | 3.7 |
Research and development costs in income statement | EUR million | 19.8 | 20.8 | 15.5 | 16.5 | 18.4 |
% of net sales | % | 1.8 | 1.7 | 1.2 | 1.5 | 1.7 |
Equity attributable to equity holders of the parent company | EUR million | 819.9 | 831.6 | 812.1 | 757.8 | 760.9 |
Non-controlling interest | EUR million | 3.8 | 4.1 | 4.2 | 3.8 | 3.6 |
Equity total | EUR million | 823.7 | 835.6 | 816.3 | 761.6 | 764.5 |
Net interest-bearing debt | EUR million | 446.7 | 325.3 | 144.4 | 143.7 | 261.1 |
Net debt/LTM EBITDA excl. IAC | ratio | 2.54 | 1.55 | 0.67 | 0.78 | 1.91 |
Working capital | EUR million | 304.2 | 337.2 | 164.5 | 134.2 | 194.4 |
Balance sheet total | EUR million | 1,754.9 | 1,585.4 | 1,435.5 | 1,342.0 | 1,364.3 |
Return on investment | % | 8.7 | 12.1 | 15.3 | 9.9 | 6.0 |
Return on equity | % | 8.4 | 12.0 | 11.1 | 9.0 | 5.3 |
Equity ratio | % | 46.9 | 52.7 | 56.9 | 56.8 | 56.0 |
Net gearing | % | 54.2 | 38.9 | 17.7 | 18.9 | 34.2 |
Personnel (FTE), average | 6,133 | 6,273 | 6,081 | 6,104 | 6,840 | |
Personnel, end of period | 7,162 | 6,595 | 6,690 | 6,411 | 6,984 | |
of which outside Finland | 6,084 | 5,432 | 5,579 | 5,348 | 5,852 |